Key Takeaway from this PR is not the fact that dos
Post# of 72440
Posted On: 11/07/2012 4:52:37 PM
Key Takeaway from this PR is not the fact that dosing is underway, as that has been expected. The big news here is :
Kevetrin has reached its initial clinical stage goal of Phase 1 human trials for solid tumors and the protocol is now being written for clinical trials in blood cancers at university-sponsored studies in Europe
That means negotiations for that trial are OVER, its a done deal, and they are just writing up the nuts and bolts of what data they want to pull from that trial. GREAT news, solid catalyst!
Kevetrin has reached its initial clinical stage goal of Phase 1 human trials for solid tumors and the protocol is now being written for clinical trials in blood cancers at university-sponsored studies in Europe
That means negotiations for that trial are OVER, its a done deal, and they are just writing up the nuts and bolts of what data they want to pull from that trial. GREAT news, solid catalyst!
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼